Shandong Pharmaceutical Glass Co.Ltd (SHA:600529)
China · Delayed Price · Currency is CNY 18.81
-0.13 (-0.69%)
Apr 29, 2026, 3:00 PM CST
SHA:600529 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 667.2 | 689.63 | 942.99 | 775.8 | 618.29 | 591.09 |
Depreciation & Amortization | 394.67 | 394.67 | 385.15 | 325.13 | 295.17 | 240.64 |
Other Amortization | 0.41 | 0.41 | - | - | - | - |
Loss (Gain) From Sale of Assets | -1.45 | -1.45 | -0.33 | 5.73 | -4.53 | -0.59 |
Asset Writedown & Restructuring Costs | 59.54 | 59.54 | 6.75 | 48.82 | 48.25 | 61.43 |
Loss (Gain) From Sale of Investments | -26.68 | -26.68 | -36.1 | -41.23 | -5.45 | -12.81 |
Provision & Write-off of Bad Debts | -4.58 | -4.58 | 2.13 | 11.42 | 12 | 10.87 |
Other Operating Activities | 243.31 | 98.43 | 39.62 | -9.62 | -22.23 | 6.25 |
Change in Accounts Receivable | 299.25 | 299.25 | -141.18 | -191.12 | -242.64 | -265.71 |
Change in Inventory | -520.12 | -520.12 | -280.14 | 125.87 | -355.41 | -155.06 |
Change in Accounts Payable | -390.26 | -390.26 | 288.01 | 6.88 | -100.67 | 275.3 |
Change in Other Net Operating Assets | -4.59 | -4.59 | -5.2 | -3.89 | 9.26 | 1.82 |
Operating Cash Flow | 699.38 | 576.92 | 1,165 | 1,048 | 252.44 | 750.44 |
Operating Cash Flow Growth | -27.10% | -50.48% | 11.17% | 315.14% | -66.36% | 32.58% |
Capital Expenditures | -334.49 | -231.86 | -647.79 | -671.53 | -710.71 | -809.26 |
Sale of Property, Plant & Equipment | 3.27 | 3.2 | 0.63 | 2.21 | 11.18 | 3.45 |
Investment in Securities | 1,410 | 50 | -508 | -112 | -796 | -74 |
Other Investing Activities | 27.54 | 30.07 | 37.31 | 36.76 | 7.15 | 12.56 |
Investing Cash Flow | 1,106 | -148.59 | -1,118 | -744.57 | -1,488 | -867.25 |
Short-Term Debt Issued | - | - | - | 12.46 | 5.16 | - |
Total Debt Issued | - | - | - | 12.46 | 5.16 | - |
Long-Term Debt Repaid | - | -6.41 | - | - | - | - |
Total Debt Repaid | -6.41 | -6.41 | - | - | - | - |
Net Debt Issued (Repaid) | -6.41 | -6.41 | - | 12.46 | 5.16 | - |
Issuance of Common Stock | - | - | - | - | 1,842 | - |
Common Dividends Paid | -370.34 | -370.34 | -464.53 | -199.08 | -178.49 | -178.49 |
Other Financing Activities | -2.08 | - | - | - | -0.96 | - |
Financing Cash Flow | -378.83 | -376.75 | -464.53 | -186.62 | 1,668 | -178.49 |
Foreign Exchange Rate Adjustments | -4.04 | 5.79 | 15.61 | 9.69 | 20.19 | -6.64 |
Net Cash Flow | 1,423 | 57.38 | -401.72 | 126.48 | 452.42 | -301.94 |
Free Cash Flow | 364.89 | 345.06 | 517.27 | 376.45 | -458.27 | -58.82 |
Free Cash Flow Growth | 7.46% | -33.29% | 37.41% | - | - | - |
Free Cash Flow Margin | 8.07% | 7.71% | 10.55% | 7.56% | -10.94% | -1.52% |
Free Cash Flow Per Share | 0.55 | 0.52 | 0.78 | 0.57 | -0.76 | -0.10 |
Cash Income Tax Paid | 330.37 | 285.73 | 274.56 | 252.97 | 137.17 | 166.19 |
Levered Free Cash Flow | 303.08 | 193.66 | 328.88 | 156.21 | -646.81 | -132.14 |
Unlevered Free Cash Flow | 303.4 | 193.98 | 328.89 | 156.36 | -646.64 | -131.96 |
Change in Working Capital | -633.04 | -633.04 | -175.16 | -68.07 | -689.05 | -146.43 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.